Urging the Congress of the United States to expand post-traumatic stress disorder treatment for veterans and service members by authorizing stellate ganglion block therapy through passage of H.R. 1947, the Treatment and Relief through Emerging and Accessible Therapy for PTSD Act.
Impact
If adopted, SR122 would have significant implications for state and federal mental health policies regarding veterans. It highlights the urgent need for innovative and effective treatments for a population that suffers from limited success with traditional therapies. The resolution brings attention to the pressing issue of veteran suicide, which is alarmingly high, and underscores the role that effective treatment options can play in preventing these tragedies. By supporting legislation that provides access to SGB therapy, the resolution aims to enhance the quality of care veterans receive.
Summary
SR122 is a Senate resolution aimed at urging the U.S. Congress to expand treatment options for post-traumatic stress disorder (PTSD) in veterans and service members. The resolution specifically advocates for the authorization of stellate ganglion block (SGB) therapy, a procedure that has shown effectiveness in alleviating PTSD symptoms such as anxiety and hyperarousal. By promoting H.R. 1947, known as the Treatment and Relief through Emerging and Accessible Therapy for PTSD Act, the resolution seeks to enhance the mental health care of veterans, who often face high rates of PTSD and related issues.
Sentiment
The sentiment surrounding SR122 appears to be supportive among lawmakers advocating for veterans' mental health. Stakeholders, including the Pennsylvania National Guard Associations and the American Legion, back the resolution, indicating a collaborative effort across various organizations. However, there may also be concerns regarding the extent to which new treatments like SGB should be integrated into existing PTSD treatment protocols. Overall, the resolution reflects a united call for improvements in care for veterans.
Contention
While SR122 is predominantly favorable, discussions may arise regarding the need for extensive research and evidence supporting the efficacy and safety of stellate ganglion block therapy. As SGB is relatively new in the context of PTSD treatments, some members may question its integration into standard treatment frameworks without comprehensive studies. The resolution's push for federal authorization could also encounter legislative hurdles, especially if there are conflicting views on resource allocation and treatment approaches for veterans' mental health.
Urging the Congress of the United States to pass H.R. 1947, the Treatment and Relief through Emerging and Accessible Therapy for PTSD Act or similar legislation dealing with stellate ganglion block therapy to veterans and members of the armed forces of the United States with post-traumatic stress disorder, during the 119th United States Congress.
Urging the Congress of the United States and the United States Department of Veterans Affairs to enable veterans to access hyperbaric oxygen therapy for both traumatic brain injury and post-traumatic stress disorder.
Urge the United States Congress to swiftly enact legislation to provide for veterans' access to treatments for traumatic brain injury and post-traumatic stress disorder
A RESOLUTION to urge the United States Congress to enact legislation and request that the Veterans Administration work to expand and improve efforts to treat traumatic brain injuries and post-traumatic stress disorder.
Relating to a pilot program awarding grants for the provision of personalized treatment protocols for veterans diagnosed with post-traumatic stress disorder.